Dearborn Partners LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 35,043 shares of the company’s stock, valued at approximately $4,215,000.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MKGAF. Trail Ridge Investment Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter worth approximately $697,000. Algert Global LLC grew its holdings in shares of Merck KGaA by 11.4% in the second quarter. Algert Global LLC now owns 90,995 shares of the company’s stock valued at $11,693,000 after acquiring an additional 9,323 shares in the last quarter. Ames National Corp bought a new position in shares of Merck KGaA in the second quarter valued at approximately $1,009,000. D.B. Root & Company LLC purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $458,000. Finally, Flavin Financial Services Inc. purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $2,994,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Shares of Merck KGaA stock opened at $163.45 on Tuesday. The business’s fifty day simple moving average is $162.78 and its 200 day simple moving average is $148.59. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The firm has a market capitalization of $21.12 billion, a P/E ratio of 24.95 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
